US To Donate Additional 500M Pfizer-BioNTech COVID-19 Vaccine Doses To Lower Income Nations - Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX)

Pfizer Inc PFE and BioNTech SE BNTX will provide the U.S. government additional 500 million doses of its COVID-19 vaccine.
The doses at a not-for-profit price will be used for donations to low- and lower-middle-income countries and the organizations that support them.
The expanded agreement brings the total number of doses to be supplied to the U.S. government for donation to these countries to one billion.
Related Link: Cashing COVID-19 Vaccine - AstraZeneca Or Pfizer.
Deliveries of the initial 500 million doses began in August 2021, and a total of one billion doses under the expanded agreement are expected to be delivered by the end of September 2022.
The current plan is to produce these doses in Pfizer's U.S. facilities in Kalamazoo, MI, Andover, MA, Chesterfield, MO, and McPherson, KS.
Overall, Pfizer and BioNTech have shipped more than 1.5 billion COVID-19 vaccine doses worldwide.
Citing sources familiar with the issue, Reuters reported that the government would pay some $7 per dose.
In June, the Biden administration agreed to buy and donate 500 million doses of the vaccine. Under the terms of that contract, the U.S. will pay Pfizer and BioNTech around $3.5 billion or $7/dose.
Price Action: PFE stock is up 0.27% at $44.04, and BNTX stock is up 0.10% at $341.7 during the premarket session on the last check Wednesday.
Image by torstensimon from Pixabay